Related Experiment Video
Updated: Jan 11, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Effects of Botrychium ternatum (Thunb) Sw. On Cytochrome P450 Activities in Rats
Jiange Yao1, Liming Hu2, Quan Zhou3
1Department of Outpatient, The Fifth Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Botrychium Ternatum (BT) significantly impacts cytochrome P450 (CYP) enzymes, increasing their expression and drug clearance. Dosage adjustments are recommended when using BT with CYP-metabolized medications.
Area of Science:
- Pharmacology
- Drug Metabolism
- Herbal Medicine Research
Background:
- Drug interactions frequently arise from cytochrome P450 (CYP) enzyme activity.
- Understanding the influence of traditional medicines on CYP enzymes is crucial for safe co-administration.
Purpose of the Study:
- To investigate the effects of Botrychium Ternatum (BT), a Chinese herbal medicine, on the activity and expression of six key CYP enzymes.
- To assess the impact of BT on liver function and drug metabolism in rats.
Main Methods:
- Twelve healthy male Sprague-Dawley rats were divided into control and BT-treated groups.
- Probe drugs were administered, and plasma concentrations were analyzed using UPLC-MS/MS.
- Enzyme expression levels were quantified via real-time fluorescence quantitative PCR, and serum biochemical indicators were assessed.
Main Results:
- BT administration led to lower area under the curve (AUC) and higher clearance rates for probe drugs.
- BT significantly upregulated the expression of the six studied CYP enzymes.
- BT treatment decreased aspartate aminotransferase levels, indicating a potential protective effect on hepatocytes.
Conclusions:
- Botrychium Ternatum (BT) enhances the activity and expression of cytochrome P450 (CYP) enzymes.
- Patients using BT concurrently with drugs metabolized by CYP enzymes may require dosage adjustments.
- Further research into BT's pharmacokinetic interactions is warranted for clinical safety.
More Related Videos
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
09:37Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Related Concept Videos
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow